[Congressional Record Volume 170, Number 115 (Thursday, July 11, 2024)]
[Senate]
[Page S5116]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2885. Ms. COLLINS submitted an amendment intended to be proposed 
by her to the bill S. 4638, to authorize appropriations for fiscal year 
2025 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

        At the end of subtitle A of title VII, add the following:

     SEC. 710. MODIFICATION OF POLICY ON USE OF MONOCLONAL 
                   ANTIBODIES FOR THE PREVENTION, TREATMENT, OR 
                   MITIGATION OF SYMPTOMS RELATED TO MILD 
                   COGNITIVE IMPAIRMENT OR ALZHEIMER'S DISEASE.

        The Secretary of Defense shall modify the policy of the 
     Department of Defense to permit the use of monoclonal 
     antibodies for the prevention, treatment, or mitigation of 
     symptoms related to mild cognitive impairment or Alzheimer's 
     disease under the TRICARE program (as defined in section 1072 
     of title 10, United States Code).
                                 ______